Document is current
Any future updates will be listed below
-
Authors
Gupta, Kshama
Perkerson, Ralph B. III
Parsons, Tammee M.
Angom, Ramacharan
Amerna, Danilyn
Burgess, Jeremy D.
Ren, Yingxue
McLean, Pamela J.
Mukhopadhyay, Debabrata
Vibhute, Prasanna
Wszolek, Zbigniew K.
Zubair, Abba C.
Quiñones-Hinojosa, Alfredo
Kanekiyo, Takahisa https://orcid.org/0000-0001-6751-9374
-
Funding
Funding for this research was provided by:
National Institute on Aging (U19AG069701)
National Institute on Aging (RF1AG071226)
Mayo Clinic (Center for Regenerative Biotherapeutics)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 13 July 2024
First Online: 29 July 2024
Declarations
:
: We utilized deidentified iPSC lines. Since 5/1/2012, our iPSC banking has been approved by Mayo Clinic IRB 12-002562: Human skin fibroblast and lymphocyte-derived induced pluripotent stem cells (iPS) and their use in studying Alzheimer’s disease (AD) and other neurodegenerative disorders. This research does not involve larger animals, clinical experiments, or primary patient-derived human tissues. Zebrafish cultures were performed as per standard protocol, accredited by Mayo Clinic animal ethics committee, and the work has been reported in line with the ARRIVE guidelines 2.0.
: Not applicable.
: The authors declare that they have no competing interests.
